Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $571.7M
Liabilities Breakdown FY2020
Total Liabilities: $48.4M
Asset Breakdown
Total Assets: $571.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.2M | 13.3% |
| Accounts Receivable | $26.2M | 4.6% |
| Inventory | $4.9M | 0.9% |
| Property, Plant & Equipment | $1.7M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $462.8M | 80.9% |
Liabilities Breakdown
Total Liabilities: $48.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.6M | 21.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.8M | 78.2% |